Gael GRIMANDI

Gael GRIMANDI


Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
FNFabien Nativel
Fabien Nativel
DRDENIS RENARD
DENIS RENARD
FHFahd Hached
Fahd Hached
PPPierre-Gabriel Pinta
Pierre-Gabriel Pinta
CDCyril D’arros
Cyril D’arros
GGGael GRIMANDI
Gael GRIMANDI
Human adipose-derived stromal cells (hASCs) are widely known for their immunomodulatory and anti-inflammatory properties. This study proposes a method to protect cells during and after their injection by encapsulation in a hydrogel using a droplet millifluidics technique. A biocompatible, self-hardening biomaterial composed of silanized-hydroxypropylmethylcellulose (Si-HPMC) hydrogel was used and dispersed in an oil continuous phase. Spherical particles with a mean diameter of 200 μm could be obtained in a reproducible manner. The viability of the encapsulated hASCs in the Si-HPMC particles was 70% after 14 days in vitro, confirming that the Si-HPMC particles supported the diffusion of nutrients, vitamins, and glucose essential for survival of the encapsulated hASCs. The combination of droplet millifluidics and biomaterials is therefore a very promising method for the development of new cellular microenvironments, with the potential for applications in biomedical engineering.

APAntoine PERPOIL
Antoine PERPOIL
GGGael GRIMANDI
Gael GRIMANDI
SBStéphane BIRKLE
Stéphane BIRKLE
JSJean-François SIMONET
Jean-François SIMONET
ACAnne CHIFFOLEAU
Anne CHIFFOLEAU
François BocquetFrançois Bocquet
François Bocquet
Biologic reference drugs and their copies, biosimilars, have a complex structure. Biosimilars need to demonstrate their biosimilarity during development but unpredictable variations can remain, such as micro-heterogeneity. The healthcare community may raise questions regarding the clinical outcomes induced by this micro-heterogeneity. Indeed, unwanted immune reactions may be induced for numerous reasons, including product variations. However, it is challenging to assess these unwanted immune reactions because of the multiplicity of causes and potential delays before any reaction. Moreover, safety assessments as part of preclinical studies and clinical trials may be of limited value with respect to immunogenicity assessments because they are performed on a standardised population during a limited period. Real-life data could therefore supplement the assessments of clinical trials by including data on the real-life use of biosimilars, such as switches. Furthermore, real-life data also include any economic incentives to prescribe or use biosimilars. This article raises the question of relevance of automating real life data processing regarding Biosimilars. The objective is to initiate a discussion about different approaches involving Machine Learning. So, the discussion is established regarding implementation of Neural Network model to ensure safety of biosimilars subject to economic incentives. Nevertheless, the application of Machine Learning in the healthcare field raises ethical, legal and technical issues that require further discussion.

1 November 2019 in Revue D'Épidémiologie Et de Santé Publique
Verified
Journal Article
Closed access
FNF. Nativel
F. Nativel
LDL. Detraz
L. Detraz
NMN. Mauduit
N. Mauduit
VRV-P. Riche
V-P. Riche
HDH. Desal
H. Desal
GGGael GRIMANDI
Gael GRIMANDI

29 October 2024 in Pharmacy
Verified
Journal Article
Open access
PDF file
FRFlorence Ranchon
Florence Ranchon
SCSebastien Chanoine
Sebastien Chanoine
ACANEPC Pedagogical Committee
ANEPC Pedagogical Committee
ADAntoine Dupuis
Antoine Dupuis
GGGael GRIMANDI
Gael GRIMANDI
Pierrick BedouchPierrick Bedouch
Pierrick Bedouch
Clinical pharmacy education varies widely between European countries, and several major changes have taken place in France. This review aims to describe the current state of pharmacy education in France, focusing on clinical pharmacy. Research into legislative texts on pharmacy education in France was conducted based on the national database “legifrance”. A complementary search on clinical pharmacy teaching methods used in France was carried out on the Medline, Embase, Pascal and Francis database for articles published from 2008 to 30 April 2021. Pharmacy studies are taught in universities and last from six to ten years, depending on the student’s chosen options. The scientific curriculum is defined at the national level. Students choose their professional path after the fourth year with specialized courses. Whatever the direction chosen, all students have several internships, including a half-time one-year hospital internship, with patient-centered hospital functions within medical and pharmaceutical teams. The status of clinical pharmacy has been enhanced under French law and regulations, improving clinical pharmacy education, which is now skill-based, in a progressive, active, and dynamic process, with community or hospital pharmacists as university teachers and closer to real-life clinical pharmacy. Teaching is increasingly innovative, and this needs to be shared and reported in the literature. Several important reforms have modernized French pharmacy studies in recent years, conferring a pivotal place for clinical pharmacy.


14 June 2018 in Preprints.org
Verified
Preprint
Open access
PDF file
FNFabien Nativel
Fabien Nativel
DRDENIS RENARD
DENIS RENARD
FHFahd Hached
Fahd Hached
PPPierre-Gabriel Pinta
Pierre-Gabriel Pinta
CDCyril D'Arros
Cyril D'Arros
GGGael GRIMANDI
Gael GRIMANDI
Human adipose derived-stromal cells (hASCs) are widely known for their immunomodulatory and anti-inflammatory properties. This study proposes a method to protect cells during and after their injection by encapsulation in a hydrogel using a droplet millifluidics technique. A biocompatible, self-hardening biomaterial composed of silanized-hydroxypropylmethylcellulose (Si-HPMC) hydrogel was used and dispersed in an oil continuous phase. Spherical particles with a mean diameter of 200 μm could be obtained in a reproducible manner. The viability of the encapsulated hASCs in the Si-HPMC particles was 70% after 14 days in vitro, confirming that the Si-HPMC particles supported the diffusion of nutrients, vitamins and glucose essential for survival of the encapsulated hASCs. The combination of droplet millifluidics and biomaterials is therefore very a very promising method for the development of new cellular microenvironments with the potential for applications in biomedical engineering.